title: [Plasmapheresis as treatment for severe hypertriglyceridemia].
authors: Katty
authors: K
authors: Manrique Franco
authors: Olga
authors: O
authors: Sánchez-Vilar Burdiel
authors: Carmen
authors: C
authors: Aragón Valera
authors: M Soledad
authors: MS
authors: Sánchez Fernández
authors: Adela
authors: A
authors: Rovira Loscos
mesh_terms: D000218:Adamantane / Q000031:analogs & derivatives / Q000627:therapeutic use; D000328:Adult; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications / Q000188:drug therapy; D018752:Diet, Fat-Restricted; D004359:Drug Therapy, Combination; D004630:Emergencies; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology; D015228:Hypertriglyceridemia / Q000097:blood / Q000150:complications / Q000178:diet therapy / Q000628:therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007328:Insulin / Q000627:therapeutic use; D008297:Male; D008687:Metformin / Q000627:therapeutic use; D009570:Nitriles / Q000627:therapeutic use; D010956:Plasmapheresis; D011759:Pyrrolidines / Q000627:therapeutic use; D000077597:Vildagliptin
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D009570:Nitriles; D011759:Pyrrolidines; D008687:Metformin; D000077597:Vildagliptin; D000218:Adamantane